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Abstract
Background: African Americans’ beliefs about end-of-life care may differ from those of whites, but racial
differences in advance care planning (ACP) outcomes are unknown.
Objective: The aim of this study was to compare the efficacy of an ACP intervention on preparation for end-of-life
decision making and post-bereavement outcomes for African Americans and whites on dialysis.
Method: A secondary analysis of data from a randomized trial comparing an ACP intervention (Sharing Patient’s
Illness Representations to Increase Trust [SPIRIT]) with usual care was conducted. There were 420 participants,
210 patient-surrogate dyads (67.4% African Americans), recruited from 20 dialysis centers in North Carolina. The
outcomes of preparation for end-of-life decision making included dyad congruence on goals of care, surrogate
decision-making confidence, a composite of the two, and patient decisional conflict assessed at 2, 6, and 12
months post-intervention. Surrogate bereavement outcomes included anxiety, depression, and post-traumatic
distress symptoms assessed at 2 weeks, and at 3 and 6 months after the patient’s death.
Results: SPIRIT was superior to usual care in improving dyad congruence (odds ration [OR]= 2.31, p= 0.018),
surrogate decision-making confidence (b = 0.18, p = 0.021), and the composite (OR= 2.19, p = 0.028) 2 months
post-intervention, but only for African Americans. SPIRIT reduced patient decisional conflict at 6 months for
whites and at 12 months for African Americans. Finally, SPIRIT was superior to usual care in reducing
surrogates’ bereavement depressive symptoms for African Americans but not for whites (b= -3.49, p= 0.003).
Conclusion: SPIRIT was effective in improving preparation for end-of-life decision-making and post-
bereavement outcomes in African Americans.
Introduction
End-stage renal disease (ESRD) currently affects640,000 people in the United States.1 Despite the ad-
vances in dialysis, adjusted all-cause mortality rates are 6 to 8
times greater for dialysis patients than for individuals in the
general age-matched Medicare population.1 The importance
of advance care planning (ACP) in dialysis care is well rec-
ognized by stakeholders, including patients, families, and
dialysis care providers.2–6 However, few studies have dem-
onstrated the beneficial impact of an ACP intervention in
dialysis patients.7
African Americans, comprising approximately 31% of the
ESRD population, are thought to prefer more aggressive
treatment at the end of life,8 to be less likely to have a do not
resuscitate (DNR) order,9 and to be less amenable to using
advance directives (ADs) compared with whites.10,11 Such
differences might be associated with health and illness expe-
riences that differ between African Americans and whites as
these experiences are influenced by socioeconomic status,
marriage, family experiences, and other cumulative life situ-
ations.12 African Americans are more likely than other racial/
ethnic groups in the United States to be religiously affiliated
and to adhere to ideologies that may influence decision making
1Nell Hodgson School of Nursing, Emory University, Atlanta, Georgia.
3School of Public Health, Department of Biostatistics, 5School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill,
North Carolina.
2School of Nursing, University of Wisconsin-Madison, Madison, Wisconsin.
4School of Nursing, Johns Hopkins University, Baltimore, Maryland.
6UNC Kidney Center, Chapel Hill, North Carolina.
Accepted August 7, 2015.
JOURNAL OF PALLIATIVE MEDICINE
Volume 19, Number 2, 2016
ª Mary Ann Liebert, Inc.
DOI: 10.1089/jpm.2015.0232
134
about issues such as discontinuation of life-sustaining treat-
ments.13 However, despite knowledge that such beliefs are
important in end-of-life decision making, little has been done
to develop and test an ACP intervention for African Americans
that takes such beliefs into consideration.14–16
To address these gaps, we tested the long-term effects of an
ACP intervention entitled SPIRIT (Sharing Patient’s Illness
Representations to Increase Trust) on preparation for end-of-
life decision making for dialysis patients and surrogates and on
bereavement outcomes for surrogates. SPIRIT was based on
the Representational Approach to Patient Education17,18 and
designed to help patients and surrogates understand the pa-
tient’s illness and implications for end-of-life decision making.
An intervention that uses the Representational Approach first
establishes an understanding of the cognitive, emotional, and
spiritual or religious aspects of the patient’s representation
(beliefs or understandings) of his or her illness. These under-
standings serve as a foundation for the interventionist to pro-
vide individualized health care information.19 Results of the
intention-to-treat analysis, reported elsewhere, revealed
SPIRIT was superior to usual care in improving preparation for
end-of-life decision making and bereavement outcomes.20
Here, as a planned analysis, we examined whether the effects
of SPIRIT differ between African Americans and whites on
preparation for end-of-life decision making for patients and
surrogates and on bereavement outcomes for surrogates.
Methods
Study design
The original study was a two-group randomized controlled
trial with measures of patient and surrogate preparedness at
baseline and 2, 6, and 12 months later, and measures of sur-
rogate bereavement outcomes at baseline, 2 weeks, and 3 and 6
months after the patient’s death. Dyads were randomized to
SPIRIT or usual care with stratification by race (African
American versus white), dialysis center type (university-
affiliated versus non-affiliated), and dialysis modality (hemo-
dialysis versus peritoneal).The University of North Carolina at
Chapel Hill Institutional Review Board (IRB) approved the
study. The clinicaltrials.gov Identifier is NCT01259011 (A
Representational Intervention to Promote Preparation for End-
of-Life Decision Making).
Setting and participants
Patients recruited from 20 free-standing outpatient dialysis
centers in eight counties in North Carolina were age 18 years
or older; self-identified African American or white, had been
on dialysis for at least 6 months prior to enrollment, had a
Charlson Comorbidity Index (CCI)21,22 score ‡6 or CCI = 5
and were hospitalized in the last 6 months, were English-
speaking, had no hearing impairment, had <3 errors on the
Short Portable Mental Status Questionnaire,23 and had an
English-speaking surrogate over age 18 who could partici-
pate. We randomized 210 dyads:141 African American dy-
ads and 69 white dyads.
Interventions
Usual care. As required by the Centers for Medicare and
Medicaid Services (CMS),24 written information on ADs was
provided to every patient on the first day of dialysis, and a
social worker encouraged patients to complete an AD and
addressed questions about life-sustaining treatments. A ne-
phrologist (or physician assistant or nurse practitioner) re-
viewed resuscitation statements with the patient to determine
whether the patient wanted a DNR order at the dialysis
center. If completed, the AD and DNR were placed in the
medical record. If there was no DNR order in the record, a full
code was presumed.
Intervention. Dyads randomized to intervention re-
ceived usual care plus SPIRIT. SPIRIT was conducted by one
of three nurse interventionists using an intervention guide.
The interventionists had at least 2 years of clinical experience
and had completed a competency-based training program.
SPIRIT included two sessions. During the first session at
the dialysis center, the interventionist assessed cognitive,
emotional, and spiritual/religious aspects of the dyad’s rep-
resentations of (beliefs and understanding about) the patient’s
illness, prognosis, and end-of-life care. This assessment
allowed the interventionist to then provide individualized
information about topics such as the effectiveness of life-
sustaining treatment for people with ESRD, and to assist the
patient in examining his/her values about life-sustaining
treatment at the end of life. The interventionist actively in-
volved the surrogate in the discussion and helped the surro-
gate prepare for being a decision-maker and for the emotional
burden of end-of-life decision making.
A goals-of-care document was completed at the end of the
session to indicate the patient’s preferences. A brief second
session was delivered 2 weeks later at the patient’s home (to
reduce the burden of travel to the center). During the session,
the patient’s goals-of-care document and resuscitation pref-
erences were reviewed again. The interventionist explored
potential family conflicts and encouraged the dyad to talk
with other family members and to complete a health care
power of attorney. The interventionist then created a written
summary of information about the patient’s end-of-life
preferences, communicated those preferences to dialysis
staff, and placed the summary in the medical record.
Of the dyads randomized to SPIRIT, 36 white dyads
(97.3%) and 71 African American dyads (98.6%) received
Session I; of those, 33 (91.7%) whites and 67 (94.4%) Afri-
can Americans received Session II. Session I averaged 85
minutes for whites and 81 minutes for African Americans.
Session II averaged 21 minutes for whites and 20 minutes for
African Americans.
Measurement
Preparedness outcomes. Dyad congruence, patient
decisional conflict, and surrogate decision-making confidence
were measured. Dyad congruence was assessed using the
goals-of-care document,15 which included two scenarios de-
scribing medical conditions that commonly occur in ESRD
patients. In the first, the patient developed a severe compli-
cation and could not speak for himself/herself; the medical
team believed recovery unlikely and continuing life-sustaining
treatment, including dialysis, would no longer be beneficial. In
the second scenario, the patient developed advanced dementia.
Each scenario had three response options: ‘‘The goals of care
should focus on delaying my death, and thus I want to continue
life-sustaining treatment,’’ ‘‘The goals of care should focus on
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my comfort and peace, and thus I do not want life-sustaining
treatment, including dialysis,’’ and ‘‘I am not sure.’’ Patient
and surrogate responses to these scenarios were compared to
determine dyad congruence—either congruent in both sce-
narios or incongruent. If both members of the dyad endorsed
‘‘I am not sure,’’ they were considered incongruent.
Patient decisional conflict was measured using the 13-item
Decisional Conflict Scale (DCS)25; higher scores indicate
greater difficulty in decision making (score range 1–5).
Surrogate decision-making confidence was measured using
the 5-item Decision Making Confidence (DMC) scale15,26 in
which higher scores reflect greater comfort in performing as a
surrogate (score range 0–4). A composite outcome was cre-
ated to differentiate surrogates who understand the patient’s
wishes and feel confident in their role from those who do not
(i.e., understand the wishes but lack confidence, misunder-
stand the wishes but feel confident, or neither understand the
patient’s wishes nor feel confident);15,26 dyads were grouped
as congruent in both scenarios and surrogate DMC score ‡3
(‘‘Confident’’ to ‘‘Very Confident’’), or not.
Bereavement outcomes. Surrogates’ symptoms of anx-
iety and depression were measured using the Hospital Anxiety
and Depression Scale27; subscale scores range from 0 to 21
with higher scores indicating greater symptom severity. The
intensity of post-traumatic distress symptoms was assessed
using the Post-Traumatic Symptoms Scale-10 (PTSS-10).28
Higher scores indicate more intense symptoms (range 10–70).
Patients completed the 12-item Functional Assessment of
Chronic Illness Therapy (FACIT-Sp),29 a reliable and vali-
dated scale that measures the extent to which individuals
have experienced spiritual well-being in the past week on a 5-
point scale from 0 (Not at All) to 4 (Very Much).30 FACIT-Sp
has three subscales (4 items each): meaning (e.g., ‘‘I feel a
sense of purpose in life’’), peace (‘‘I feel peaceful’’), and faith
(‘‘My illness has strengthened my faith or spiritual beliefs’’).
A higher score indicates greater spiritual well-being.
Statistical analysis
Descriptive statistics were used to summarize participants’
characteristics. v2 tests and t tests or analysis of variance were
performed as appropriate to compare group difference within
race and to compare African Americans with whites in
baseline characteristics.
Most missing data on preparedness outcomes were due to
deaths of patients (n= 30). Because the study was not pow-
ered for formal testing of the interaction between SPIRIT and
race, we examined intervention effects within each race using
generalized estimating equation (GEE) methods.31 For
preparation for end-of-life decision-making outcomes, a
group indicator, time, the baseline value, and the interaction
between SPIRIT and time were included in GEE models for
each racial group. For bereavement outcomes, SPIRIT-time
interaction was not included in the models due to the small
sample size (n = 45).
To identify potential covariates associated with the study
outcomes within each race, the baseline characteristics (e.g.,
age) were examined using GEE models adjusting for inter-
vention, time, and the baseline value of each outcome. Then,
we entered the covariates that were significantly associated
with any of the study outcomes into a GEE model to examine
the effect of the covariate on the outcome within race after
adjusting for intervention, time, the interaction between
SPIRIT and time, and the baseline value of the outcome. All
analyses were conducted using SAS software version 9.3
(SAS Institute Inc., Cary, NC).
Results
Sample description
African Americans comprised 67.1% (n= 141) of the
sample. Compared with whites, African American patients
were more likely to be women (66.7% versus 37.7%,
v2 = 15.9, p< 0.001), younger (mean [M] = 60.6 versus 65.2,
t = 2.9, p = 0.005), on dialysis for a longer time (M = 4.9
versus 3.1, t = 3.6, p = 0.003), have less education (M= 12.5
versus 13.4, t= 2.1, p = 0.04), have lower incomes (M = 3.1
versus 4.1, t= 4.5, p < 0.001), rate the importance of spiritu-
ality more highly (M = 3.4 versus 2.9, t = 5.1, p< 0.001), and
have a higher total spiritual well-being (FACIT-Sp) score
(M = 39.0 versus 33.3, t = 5.1, p < 0.001) and subscale scores
(all ps < 0.01), and be less likely to have an advance directive
(11.3% versus 33.3%, v2 = 14.8, p< 0.001).
African American and white surrogates were similar in
baseline characteristics except that African American surro-
gates were more likely to rate the importance of spirituality in
life higher compared with whites (M = 3.5 versus 3.1, t = 3.2,
p = 0.002). The SPIRIT and control groups within race were
similar in baseline characteristics. Table 1 presents baseline
characteristics of participants by racial group.
The mean age of the 45 patients who died during the study
was 64.6 (standard deviation [SD]= 12.6). Mean (SD) survival
months after randomization for the 21 deceased whites was
11.5 (9.2), and for the 24 African Americans was 13.6 (10.8).
Within race, survival months between the SPIRIT and control
groups were similar. Patients who died and their surrogate’s
sociodemographic characteristics were similar between SPIR-
IT and control groups within race. Five whites and five African
American patients died suddenly requiring no surrogate deci-
sion making; 16 white surrogates and 19 African American
surrogates were involved in end-of-life decision making.
Intervention effects on outcomes by race
Preparedness. The effect of SPIRIT on dyad congru-
ence was not significant for whites at any time point (Table 2),
whereas for African Americans, the number of dyads con-
gruent in goals of care was significantly higher in SPIRIT
than in control at 2 months (OR = 2.31 [95% confidence in-
terval (CI), 1.16 to 4.60]; p = 0.018). SPIRIT significantly
reduced patient decisional conflict at 6 months for whites
(b = -0.24 [95% CI, -0.44 to -0.04]; p= 0.018) and at 12
months for African Americans (b = -0.18 [95% CI, -0.33 to
-0.03]; p = 0.021). SPIRIT did not improve surrogate
decision-making confidence for whites but did so at 2 months
for African Americans (b = 0.18 [95% CI, 0.03 to 0.33];
p = 0.021). There was no difference between SPIRIT and
controls in the composite outcome for whites; but African
Americans in SPIRIT fared better at 2 months (OR = 2.19
[95% CI, 1.09 to 4.38]; p = 0.028) than did controls.
Bereavement. Figure 1 presents the intervention effects
on anxiety and depressive symptoms and post-traumatic
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Table 1. Baseline Characteristics of Participants by Group within Race
Characteristics
Participants, no. (%)
Whites (n = 69) African Americans (n = 141)
SPIRIT
(n = 37)
Control
(n= 32)
SPIRIT
(n = 72)
Control
(n = 69)
Patient, sociodemographic
Age, mean (SD), years 63.8 (12.5) 66.8 (11.0) 59.6 (10.6) 61.5 (10.8)
Women 14 (37.8) 12 (37.5) 51 (70.8) 43 (62.3)
Marital status
Married/living with partner 22 (59.5) 16 (50.0) 34 (47.2) 27 (39.1)
Divorced/separated/widowed 12 (32.4) 15 (46.9) 28 (38.9) 34 (49.3)
Never married 3 (8.1) 1 (3.1) 10 (13.9) 8 (11.6)
Formal education completed, mean (SD), years 13.7 (3.4) 13.0 (3.2) 12.8 (2.7) 12.2 (2.6)
Extent of following religious customs
Never/sometimes 14 (37.8) 15 (46.9) 17 (23.6) 25 (36.2)
Frequently/always 23 (63.1) 17 (53.1) 55 (76.4) 44 (63.8)
Importance of spirituality in life
Not at all/somewhat important 13 (35.1) 10 (31.3) 5 (6.9) 4 (5.8)
Very/extremely important 24 (73.0) 22 (68.8) 67 (93.1) 65 (94.2)
Annual income
<$20,000 13 (35.1) 12 (37.5) 40 (55.6) 41 (59.4)
$20,000–$50,000 18 (48.6) 12 (37.5) 22 (30.6) 21 (30.4)
>$50,000 6 (16.2) 7 (21.9) 8 (11.1) 6 (8.7)
Refused to answer 0 1 (3.1) 2 (2.8) 2 (2.9)
Previously lost a close family member or a friend 37 (100) 31 (98.9) 71 (98.6) 67 (97.1)
Involved in tough medical decisions
for the lost family member or friend
14 (37.8) 7 (21.9) 22 (30.6) 18 (26.1)
FACIT-Sp spiritual well-being total, mean (SD)a 32.8 (8.1) 33.9 (8.1) 39.1 (7.2) 39.0 (7.6)
FACIT-meaning subscale 11.7 (3.2) 11.8 (2.7) 13.0 (2.7) 13.2 (2.9)
FACIT-peace 10.0 (3.5) 10.5 (3.0) 11.9 (3.1) 11.9 (3.5)
FACIT-faith 11.2 (3.8) 11.6 (4.2) 14.1 (2.5) 14.1 (2.5)
Patient, clinical
Hemodialysis 33 (89.2) 28 (87.5) 72 (100) 68 (98.6)
Years on dialysis
Median (IQR) 2.3 (1.1 – 4.5) 2.0 (1.1–4.3) 4.6 (2.3–6.9) 2.6 (1.4–5.3)
Mean (SD) 3.2 (3.0) 2.9 (2.3) 5.1 (3.5) 4.7 (5.6)
CCI illness severity, mean (SD) 8.4 (1.9) 8.3 (2.2) 8.1 (1.8) 8.1 (1.6)
Has an advance directive 13 (35.1) 10 (31.3) 8 (11.1) 8 (11.6)
Do not resuscitate order at the center 4 (10.8) 1 (3.1) 2 (2.8) 1 (1.4)
Surrogate, sociodemographic
Relationship to patient
Spouse/partner 19 (51.4) 14 (43.8) 25 (34.7) 23 (33.3)
Parent 7 (18.9) 14 (43.8) 20 (27.8) 24 (34.8)
Sibling 3 (8.1) 1 (3.1) 13 (18.1) 10 (14.5)
Child 3 (8.1) 1 (3.1) 5 (6.9) 3 (4.3)
Friend 5 (13.5) 1 (3.1) 1 (1.4) 3 (4.3)
Other(e.g., other relatives, in-laws) 0 1 (3.1) 8 (11.1) 6 (8.7)
Age, mean (SD), years 56.2 (13.5) 56.6 (14.6) 53.1 (12.9) 52.9 (14.0)
Women 27 (73.0) 28 (87.5) 48 (66.7) 49 (71.0)
Marital status
Married/living with partner 29 (78.4) 25 (78.2) 44 (61.1) 38 (55.1)
Divorced/separated/widowed 5 (13.5) 6 (18.7) 14 (19.4) 16 (23.2)
Never married 1 3 (8.1) 1 (3.1) 14 (19.4) 15 (21.7)
Formal education completed, mean (SD), years 13.6 (2.9) 13.8 (1.7) 13.5 (2.4) 13.1 (2.1)
Extent of following religious customs
Never/sometimes 8 (21.6) 7 (21.9) 19 (26.4) 13 (18.8)
Frequently/always 29 (78.3) 25 (78.1) 53 (73.6) 56 (81.2)
Importance of spirituality in life
Not at all/somewhat important 4 (10.8) 10 (31.3) 4 (5.6) 4 (5.8)
Very/extremely important 33 (89.2) 22 (68.8) 68 (94.5) 65 (94.2)
Annual income
< $20,000 8 (21.6) 7 (21.9) 20 (27.8) 21 (30.4)
$20,000–$50,000 19 (51.4) 12 (37.5) 32 (44.4) 31 (44.9)
>$50,000 9 (24.3) 12 (37.5) 17 (23.6) 13 (18.8)
Refused to answer 1 (2.7) 1 (3.1) 3 (4.2) 4 (5.8)
Previously lost a close family member or a friend 34 (91.9) 31 (96.9) 69 (95.8) 67 (97.1)
Involved in tough medical decisions
for the lost family member or friend
16 (43.2) 9 (28.1) 23 (31.9) 26 (37.7)
aPeterman et al.29 FACIT-Sp total scores range from 0 to 48, with a higher score indicating greater spiritual well-being.
Due to rounding up, percentages may not add up to 100.
CCI, Charlson Comorbidity Index; FACIT, Functional Assessment of Chronic Illness Therapy; IRQ, interquartile range; SD, standard deviation; SPIRIT,
Sharing Patient’s Illness Representations to Increase Trust.
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symptom scores by race after adjusting for time and the
baseline value. At 2 weeks post-death, both SPIRIT and
control groups for both races had a slight increase in these
symptoms. After adjusting for time and the baseline value,
there was a significant intervention effect on reducing de-
pressive symptoms for African Americans (b =-3.49 [95%
CI, -5.82 to -1.17]; p = 0.003).
Potential covariates associated with outcomes
We examined the bivariate relationships between the
baseline characteristics that differed between African
Americans and whites (described above) and study outcomes.
Only spiritual well-being (FACIT-Sp) and comorbidity
(CCI) were significantly associated with preparation for end-
of-life decision making. No surrogate baseline characteristics
were associated with surrogates’ post-death bereavement
outcomes.
Table 3 presents the relationships of FACIT subscales and
CCI with preparation for end-of-life decision making after
adjusting for intervention group, time, the interaction be-
tween intervention group and time, and the baseline value of
each outcome. One spiritual well-being subscale, FACIT-
meaning, was inversely associated with dyad congruence
Table 2. Intervention Effects on the Preparedness Outcomes by Racea
Outcomes SPIRIT Control
Odds ratio or regression
coefficient(95% CI) P value
Dyad congruence, no. (%)
Whites (n= 37) (n = 32)
Baseline 21 (56.8) 18 (56.3) -
2-month follow-up 24 (68.6) 20 (64.5) 1.14 (0.40 to 3.21) 0.81
6-month follow-up 26 (78.8) 23 (79.3) 0.76 (0.20 to 2.87) 0.69
12-month follow-up 17 (65.4) 19 (82.6) 0.32 (0.08 to 1.24) 0.10
African Americans (n = 72) (n = 69)
Baseline 26 (36.1) 25 (36.3) -
2-month follow-up 40 (60.6) 28 (40.6) 2.31 (1.16 to 4.60) 0.018
6-month follow-up 40 (64.5) 36 (53.7) 1.45 (0.69 to 3.05) 0.32
12-month follow-up 34 (57.6) 33 (52.4) 1.16 (0.57 to 2.39) 0.68
Patient DCS, mean (SD)
Whites
Baseline 1.7 (0.5) 1.7 (0.4) -
2-month follow-up 1.6 (0.4) 1.7 (0.4) -0.15 (-0.32 to 0.01) 0.069
6-month follow-up 1.5 (0.5) 1.8 (0.4) -0.24 (-0.44 to -0.04) 0.018
12-month follow-up 1.5 (0.4) 1.7 (0.4) -0.21 (-0.43 to 0.006) 0.056
African Americans
Baseline 1.6 (0.5) 1.7 (0.6) -
2-month follow-up 1.8 (0.5) 1.7 (0.4) 0.06 (-0.08 to 0.21) 0.41
6-month follow-up 1.7 (0.4) 1.8 (0.4) -0.05 (-0.19 to 0.08) 0.45
12-month follow-up 1.7 (0.4) 1.9 (0.5) -0.18 (-0.33 to -0.03) 0.021
Surrogate DMC, mean (SD)
Whites
Baseline 3.4 (0.5) 3.7 (0.4) -
2-month follow-up 3.7 (0.3) 3.7 (0.3) 0.006 (-0.13 to 0.14) 0.93
6-month follow-up 3.7 (0.3) 3.7 (0.3) 0.008 (-0.15 to 0.17) 0.93
12-month follow-up 3.8 (0.3) 3.7 (0.4) 0.04 (-0.15 to 0.22) 0.69
African Americans
Baseline 3.6 (0.6) 3.6 (0.5) -
2-month follow-up 3.7 (0.4) 3.6 (0.5) 0.18 (0.03 to 0.33) 0.021
6-month follow-up 3.7 (0.5) 3.6 (0.5) 0.15 (-0.009 to 0.31) 0.064
12-month follow-up 3.7 (0.4) 3.7 (0.5) 0.05 (-0.11 to 0.21) 0.52
Composite outcome, no. (%)
Whites
Baseline 21 (56.8) 18 (56.3) -
2-month follow-up 24 (68.6) 20 (64.5) 1.13 (0.40 to 3.22) 0.82
6-month follow-up 25 (75.8) 23 (79.3) 0.62 (0.17 to 2.28) 0.47
12-month follow-up 17 (65.4) 18 (78.3) 0.43 (0.12 to 1.53) 0.19
African Americans
Baseline 25 (34.7) 25 (36.3) -
2-month follow-up 38 (57.6) 27 (39.1) 2.19 (1.09 to 4.38) 0.028
6-month follow-up 39 (62.9) 32 (47.8) 1.78 (0.86 to 3.69) 0.12
12-month follow-up 34 (57.6) 31 (49.2) 1.36 (0.66 to 2.77) 0.40
aEach GEE model included a group indicator, time, the baseline and the interaction between intervention and time.
CI, confidence interval; DCS, Decisional Conflict Scale; DMC, Decision-Making Confidence; SD, standard deviation; SPIRIT, Sharing
Patient’s Illness Representations to Increase Trust.
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and the composite, but only for African Americans; a 1 SD
( = 2.8) increase in this score was associated with 25% re-
duction in the odds of the dyad being congruent and 34%
reduction in the odds of having a better composite outcome.
CCI was positively associated with dyad congruence, surro-
gate decision-making confidence (b = 0.04 [95% CI, 0.01 to
0.08]; p = 0.026), and the composite, but only for African
Americans; a 1 SD ( = 1.7) increase in CCI was associated
with 36% increase in the odds of the dyad being congruent
and 46% increase in the odds of a better composite outcome.
Discussion
SPIRIT was effective in improving preparation for end-
of-life decision making and post-bereavement outcomes in
African Americans. SPIRIT reduced patient decisional con-
flict at 6 months for whites and at 12 months for African
Americans. Finally, SPIRIT reduced surrogates’ bereave-
ment depressive symptoms for African Americans. However,
we did not find such effects in whites.
Data on differential effects of psychosocial and educa-
tional interventions between African Americans and whites
are rare and inconsistent mainly because only a small pro-
portion of African Americans are included in most studies.32
However, in a study of peer mentoring on AD completion and
psychosocial outcomes in 208 dialysis patients (37% to 39%
African Americans) a greater percentage of patients receiv-
ing peer mentoring completed an AD compared with those in
the control groups,14 an effect that was significant for African
Americans but not for whites. Furthermore, the intervention
showed a significant increase in subjective well-being in
African Americans but not in whites. These two interven-
tions, SPIRIT and peer mentoring, might align with African
Americans’ culture and familial, religious, and communal
frame of reference33 by including a family member in the
intervention (SPIRIT) or by using a peer-led intervention.
Our study revealed that whites in the control group im-
proved in dyad congruence over time as they simply were
asked to think about the scenarios in the goals-of-care doc-
ument and answer thought-provoking questions repeatedly.
This phenomenon, known as assessment effects,34–36 ap-
peared to be as effective as SPIRIT for whites. However, for
African Americans, controls did not benefit from assessment
effects as much; rather, SPIRIT was needed to improve dyad
congruence.
The CCI was positively associated and the FACIT-
meaning subscale inversely associated with the preparedness
outcomes among African Americans but not whites. The
explanation for the positive association between CCI and
dyad congruence might be that the patient’s illness severity is
visible to both patient and surrogate, thereby leading to
congruence within the dyad. In contrast, the degree to which
African American patients find purpose in life despite their
severe illness may not be visible and may be too personal to
FIG. 1. Intervention effects on bereavement outcomes by race. Each p value is based on a generalized estimating equation
(GEE) model adjusted for time and the baseline for each outcome. PTSS, Post-Traumatic Symptoms Scale.
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share with the surrogate. This lack of visibility and lack of
sharing might in turn lead the surrogate to misunderstand the
patient’s end-of-life preferences contributing to dyad incon-
gruence. The literature consistently suggests the importance of
spirituality in end-of-life decision making for many African
Americans.9,37–46 Our study may offer additional data on the
relationships between spiritual well-being and outcomes of
ACP for African Americans, but further research is warranted.
Studies of bereaved family members of dialysis patients are
rare, making it difficult to interpret why African American
surrogates benefited from SPIRIT to a greater extent than did
white surrogates. Although racial differences in depressive
symptomatology have been reported,47,48 literature on racial
differences in depression following the death of a loved one is
limited, and no studies have compared African Americans
with whites with respect to the impact of an ACP interven-
tion on bereaved family members. One study has shown that
African American caregivers of relatives with Alzheimer’s
disease reported greater perceived loss than did whites when a
relative died.49 Similarly, our control group data reveal that
depressive symptom scores in African American surrogates
increased post-bereavement, supporting the adverse impact of
the death of a loved one on African American surrogates. In
contrast, in the SPIRIT group depressive symptom scores in
African American surrogates decreased.
Although we found significant effects of SPIRIT in Afri-
can Americans but not in whites, the original study was not
powered to formally test the interaction between SPIRIT and
race and to estimate racial effects. Thus, our analytic ap-
proach was exploratory. We used the self-identified race/
ethnicity category for the analysis, which may be limited to
capture the complex ethnic identity. Also, the original study
was conducted in a single region in the United States and the
data may not be generalizable to other regions or other in-
dividuals with similar characteristics. Nonetheless, our
findings suggest that SPIRIT, an ACP intervention, is effec-
tive in improving preparation for end-of-life decision making
and post-bereavement outcomes in African Americans.
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